These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
171 related articles for article (PubMed ID: 8706243)
21. Immunohistochemical detection of bcl2, p53, mdm2 and p21/waf1 proteins in small-cell lung carcinomas. Stefanaki K; Rontogiannis D; Vamvouka C; Bolioti S; Chaniotis V; Sotsiou F; Vlychou M; Delidis G; Kakolyris S; Georgoulias V; Kanavaros P Anticancer Res; 1998; 18(3A):1689-95. PubMed ID: 9673391 [TBL] [Abstract][Full Text] [Related]
22. Prognostic value of simultaneous expression of p21 and mdm2 in breast carcinomas treated by adjuvant chemotherapy with antracyclin. Mathoulin-Portier MP; Viens P; Cowen D; Bertucci F; Houvenaeghel G; Geneix J; Puig B; Bardou VJ; Jacquemier J Oncol Rep; 2000; 7(3):675-80. PubMed ID: 10767389 [TBL] [Abstract][Full Text] [Related]
23. The mutant p53-conformation modifying drug, CP-31398, can induce apoptosis of human cancer cells and can stabilize wild-type p53 protein. Takimoto R; Wang W; Dicker DT; Rastinejad F; Lyssikatos J; el-Deiry WS Cancer Biol Ther; 2002; 1(1):47-55. PubMed ID: 12174820 [TBL] [Abstract][Full Text] [Related]
24. Human melanoma cell lines selected in vitro displaying various levels of drug resistance against cisplatin, fotemustine, vindesine or etoposide: modulation of proto-oncogene expression. Kern MA; Helmbach H; Artuc M; Karmann D; Jurgovsky K; Schadendorf D Anticancer Res; 1997; 17(6D):4359-70. PubMed ID: 9494534 [TBL] [Abstract][Full Text] [Related]
25. Oncoprotein expression of E6 and E7 does not prevent 5-fluorouracil (5FU) mediated G1/S arrest and apoptosis in 5FU resistant carcinoma cell lines. Didelot C; Mirjolet JF; Barberi-Heyob M; Ramacci C; Teiten MH; Merlin JL Int J Oncol; 2003 Jul; 23(1):81-7. PubMed ID: 12792779 [TBL] [Abstract][Full Text] [Related]
26. Antisense anti-MDM2 oligonucleotides as a novel therapeutic approach to human breast cancer: in vitro and in vivo activities and mechanisms. Wang H; Nan L; Yu D; Agrawal S; Zhang R Clin Cancer Res; 2001 Nov; 7(11):3613-24. PubMed ID: 11705884 [TBL] [Abstract][Full Text] [Related]
27. Mdm2 and the p53 pathway in human pituitary adenomas. Suliman M; Royds J; Cullen D; Timperley W; Powell T; Battersby R; Jones TH Clin Endocrinol (Oxf); 2001 Mar; 54(3):317-25. PubMed ID: 11298083 [TBL] [Abstract][Full Text] [Related]
28. A recombinant adenovirus expressing wild type p53 induces apoptosis in drug-resistant human breast cancer cells: a gene therapy approach for drug-resistant cancers. Seth P; Katayose D; Li Z; Kim M; Wersto R; Craig C; Shanmugam N; Ohri E; Mudahar B; Rakkar AN; Kodali P; Cowan K Cancer Gene Ther; 1997; 4(6):383-90. PubMed ID: 9408609 [TBL] [Abstract][Full Text] [Related]
29. Expression of p53, p21, mdm2, Rb, bax and Ki67 proteins in lymphomas of the mucosa-associated lymphoid (MALT) tissue. Stefanaki K; Tzardi M; Kouvidou C; Chaniotis V; Bolioti M; Vlychou M; Zois M; Kakolyris S; Delides G; Rontogianni D; Georgoulias V; Kanavaros P Anticancer Res; 1998; 18(4A):2403-8. PubMed ID: 9703886 [TBL] [Abstract][Full Text] [Related]
30. Aberrant expression of pRb, p16, p14ARF, MDM2, p21 and p53 in squamous cell carcinomas of lung. Xue Q; Sano T; Kashiwabara K; Oyama T; Nakajima T Jpn J Cancer Res; 2001 Mar; 92(3):285-92. PubMed ID: 11267938 [TBL] [Abstract][Full Text] [Related]
31. Cell-specific transcriptional activation of the mdm2-gene by ectopically expressed wild-type form of a temperature-sensitive mutant p53. Knippschild U; Kolzau T; Deppert W Oncogene; 1995 Aug; 11(4):683-90. PubMed ID: 7651732 [TBL] [Abstract][Full Text] [Related]
33. Mutant p53-induced immortalization of primary human mammary epithelial cells. Gao Q; Hauser SH; Liu XL; Wazer DE; Madoc-Jones H; Band V Cancer Res; 1996 Jul; 56(13):3129-33. PubMed ID: 8674072 [TBL] [Abstract][Full Text] [Related]
34. Abrogation of p53 function affects gadd gene responses to DNA base-damaging agents and starvation. Zhan Q; Fan S; Smith ML; Bae I; Yu K; Alamo I; O'Connor PM; Fornace AJ DNA Cell Biol; 1996 Oct; 15(10):805-15. PubMed ID: 8892753 [TBL] [Abstract][Full Text] [Related]
35. p53 expression in normal versus transformed mammalian cells. Moro F; Ottaggio L; Bonatti S; Simili M; Miele M; Bozzo S; Abbondandolo A Carcinogenesis; 1995 Oct; 16(10):2435-40. PubMed ID: 7586148 [TBL] [Abstract][Full Text] [Related]
37. Fas-mediated apoptosis is dependent on wild-type p53 status in human cancer cells expressing a temperature-sensitive p53 mutant alanine-143. Li Y; Raffo AJ; Drew L; Mao Y; Tran A; Petrylak DP; Fine RL Cancer Res; 2003 Apr; 63(7):1527-33. PubMed ID: 12670900 [TBL] [Abstract][Full Text] [Related]
38. Adenovirus-mediated transfer of wild-type p53 gene sensitizes TNF resistant MCF7 derivatives to the cytotoxic effect of this cytokine: relationship with c-myc and Rb. Ameyar M; Shatrov V; Bouquet C; Capoulade C; Cai Z; Stancou R; Badie C; Haddada H; Chouaib S Oncogene; 1999 Sep; 18(39):5464-72. PubMed ID: 10498900 [TBL] [Abstract][Full Text] [Related]
39. Immunohistochemical expression of the p53, mdm2, p21/Waf-1, Rb, p16, Ki67, cyclin D1, cyclin A and cyclin B1 proteins and apoptotic index in T-cell lymphomas. Kanavaros P; Bai M; Stefanaki K; Poussias G; Rontogianni D; Zioga E; Gorgoulis V; Agnantis NJ Histol Histopathol; 2001 Apr; 16(2):377-86. PubMed ID: 11332692 [TBL] [Abstract][Full Text] [Related]